Abstract

Erythropoietin is used to treat anemia and improve quality of life in cancer patients receiving chemotherapy. However, erythropoietin has been associated with decreased survival in several recent cancer treatment trials. Now, another study raises concern. Canadian researchers randomized patients with advanced non-small-cell lung cancer and hemoglobin levels …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call